APO Research
Talk to an analyst

APO RESEARCH · REPORT

C5 Complement Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global C5 Complement Inhibitor Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchC5 Complement Inhibitor Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal C5 Complement Inhibitor Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal C5 Complement Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C5 Complement Inhibitor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal C5 Complement Inhibitor Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global C5 Complement Inhibitor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for C5 Complement Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for C5 Complement Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for C5 Complement Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for C5 Complement Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of C5 Complement Inhibitor include Alexion. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for C5 Complement Inhibitor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of C5 Complement Inhibitor, also provides the sales of main regions and countries. Of the upcoming market potential for C5 Complement Inhibitor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the C5 Complement Inhibitor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global C5 Complement Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for C5 Complement Inhibitor sales, projected growth trends, production technology, application and end-user industry.

C5 Complement Inhibitor Segment by Company

Alexion

C5 Complement Inhibitor Segment by Type

Eculizumab

Raflizumab

C5 Complement Inhibitor Segment by Application

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Atypical Hemolytic Uremic Syndrome (aHUS)

Other

C5 Complement Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C5 Complement Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C5 Complement Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C5 Complement Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of C5 Complement Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of C5 Complement Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C5 Complement Inhibitor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C5 Complement Inhibitor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Eculizumab Major Manufacturers Table 3. Raflizumab Major Manufacturers Table 4. Global C5 Complement Inhibitor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Paroxysmal Nocturnal Hemoglobinuria (PNH) Major Manufacturers Table 6. Atypical Hemolytic Uremic Syndrome (aHUS) Major Manufacturers Table 7. Other Major Manufacturers Table 8. C5 Complement Inhibitor Industry Trends Table 9. C5 Complement Inhibitor Industry Drivers Table 10. C5 Complement Inhibitor Industry Opportunities and Challenges Table 11. C5 Complement Inhibitor Industry Restraints Table 12. Global C5 Complement Inhibitor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global C5 Complement Inhibitor Revenue by Region (2021-2026) & (US$ Million) Table 14. Global C5 Complement Inhibitor Revenue by Region (2027-2032) & (US$ Million) Table 15. Global C5 Complement Inhibitor Revenue Market Share by Region (2021-2026) Table 16. Global C5 Complement Inhibitor Revenue Market Share by Region (2027-2032) Table 17. Global C5 Complement Inhibitor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global C5 Complement Inhibitor Sales by Region (2021-2026) & (k units) Table 19. Global C5 Complement Inhibitor Sales by Region (2027-2032) & (k units) Table 20. Global C5 Complement Inhibitor Sales Market Share by Region (2021-2026) Table 21. Global C5 Complement Inhibitor Sales Market Share by Region (2027-2032) Table 22. Global C5 Complement Inhibitor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global C5 Complement Inhibitor Revenue Market Share by Manufacturers (2021-2026) Table 24. Global C5 Complement Inhibitor Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global C5 Complement Inhibitor Sales Market Share by Manufacturers (2021-2026) Table 26. Global C5 Complement Inhibitor Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global C5 Complement Inhibitor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global C5 Complement Inhibitor Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global C5 Complement Inhibitor Manufacturers, Product Type & Application Table 30. Global C5 Complement Inhibitor Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global C5 Complement Inhibitor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global C5 Complement Inhibitor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global C5 Complement Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 35. Global C5 Complement Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 36. Global C5 Complement Inhibitor Revenue Market Share by Type (2021-2026) Table 37. Global C5 Complement Inhibitor Revenue Market Share by Type (2027-2032) Table 38. Global C5 Complement Inhibitor Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 40. Global C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 41. Global C5 Complement Inhibitor Sales Market Share by Type (2021-2026) Table 42. Global C5 Complement Inhibitor Sales Market Share by Type (2027-2032) Table 43. Global C5 Complement Inhibitor Price by Type (2021-2026) & (US$/unit) Table 44. Global C5 Complement Inhibitor Price by Type (2027-2032) & (US$/unit) Table 45. Global C5 Complement Inhibitor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global C5 Complement Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 47. Global C5 Complement Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 48. Global C5 Complement Inhibitor Revenue Market Share by Application (2021-2026) Table 49. Global C5 Complement Inhibitor Revenue Market Share by Application (2027-2032) Table 50. Global C5 Complement Inhibitor Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 52. Global C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 53. Global C5 Complement Inhibitor Sales Market Share by Application (2021-2026) Table 54. Global C5 Complement Inhibitor Sales Market Share by Application (2027-2032) Table 55. Global C5 Complement Inhibitor Price by Application (2021-2026) & (US$/unit) Table 56. Global C5 Complement Inhibitor Price by Application (2027-2032) & (US$/unit) Table 57. Alexion Company Information Table 58. Alexion Business Overview Table 59. Alexion C5 Complement Inhibitor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Alexion C5 Complement Inhibitor Product Portfolio Table 61. Alexion Recent Development Table 62. North America C5 Complement Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 63. North America C5 Complement Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 64. North America C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 65. North America C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 66. North America C5 Complement Inhibitor Sales Price by Type (2021-2026) & (US$/unit) Table 67. North America C5 Complement Inhibitor Sales Price by Type (2027-2032) & (US$/unit) Table 68. North America C5 Complement Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 69. North America C5 Complement Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 70. North America C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 71. North America C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 72. North America C5 Complement Inhibitor Sales Price by Application (2021-2026) & (US$/unit) Table 73. North America C5 Complement Inhibitor Sales Price by Application (2027-2032) & (US$/unit) Table 74. North America C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America C5 Complement Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 76. North America C5 Complement Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 77. North America C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 78. North America C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 79. North America C5 Complement Inhibitor Sales by Country (2027-2032) & (k units) Table 80. North America C5 Complement Inhibitor Sales Price by Country (2021-2026) & (US$/unit) Table 81. North America C5 Complement Inhibitor Sales Price by Country (2027-2032) & (US$/unit) Table 82. United States C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 83. Canada C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 84. Mexico C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 85. Europe C5 Complement Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe C5 Complement Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 88. Europe C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 89. Europe C5 Complement Inhibitor Sales Price by Type (2021-2026) & (US$/unit) Table 90. Europe C5 Complement Inhibitor Sales Price by Type (2027-2032) & (US$/unit) Table 91. Europe C5 Complement Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe C5 Complement Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 94. Europe C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 95. Europe C5 Complement Inhibitor Sales Price by Application (2021-2026) & (US$/unit) Table 96. Europe C5 Complement Inhibitor Sales Price by Application (2027-2032) & (US$/unit) Table 97. Europe C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe C5 Complement Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. Europe C5 Complement Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. Europe C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 101. Europe C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 102. Europe C5 Complement Inhibitor Sales by Country (2027-2032) & (k units) Table 103. Europe C5 Complement Inhibitor Sales Price by Country (2021-2026) & (US$/unit) Table 104. Europe C5 Complement Inhibitor Sales Price by Country (2027-2032) & (US$/unit) Table 105. Germany C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 106. France C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 107. U.K. C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 108. Italy C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 109. Russia C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 110. Spain C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 111. Netherlands C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 112. Switzerland C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 113. Sweden C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 114. Poland C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 115. China C5 Complement Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 116. China C5 Complement Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 117. China C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 118. China C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 119. China C5 Complement Inhibitor Sales Price by Type (2021-2026) & (US$/unit) Table 120. China C5 Complement Inhibitor Sales Price by Type (2027-2032) & (US$/unit) Table 121. China C5 Complement Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 122. China C5 Complement Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 123. China C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 124. China C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 125. China C5 Complement Inhibitor Sales Price by Application (2021-2026) & (US$/unit) Table 126. China C5 Complement Inhibitor Sales Price by Application (2027-2032) & (US$/unit) Table 127. Asia C5 Complement Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia C5 Complement Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 130. Asia C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 131. Asia C5 Complement Inhibitor Sales Price by Type (2021-2026) & (US$/unit) Table 132. Asia C5 Complement Inhibitor Sales Price by Type (2027-2032) & (US$/unit) Table 133. Asia C5 Complement Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia C5 Complement Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 136. Asia C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 137. Asia C5 Complement Inhibitor Sales Price by Application (2021-2026) & (US$/unit) Table 138. Asia C5 Complement Inhibitor Sales Price by Application (2027-2032) & (US$/unit) Table 139. Asia C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia C5 Complement Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia C5 Complement Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 143. Asia C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 144. Asia C5 Complement Inhibitor Sales by Country (2027-2032) & (k units) Table 145. Asia C5 Complement Inhibitor Sales Price by Country (2021-2026) & (US$/unit) Table 146. Asia C5 Complement Inhibitor Sales Price by Country (2027-2032) & (US$/unit) Table 147. Japan C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 148. South Korea C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 149. India C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 150. Australia C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 151. Taiwan C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 153. SAMEA C5 Complement Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA C5 Complement Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA C5 Complement Inhibitor Sales by Type (2021-2026) & (k units) Table 156. SAMEA C5 Complement Inhibitor Sales by Type (2027-2032) & (k units) Table 157. SAMEA C5 Complement Inhibitor Sales Price by Type (2021-2026) & (US$/unit) Table 158. SAMEA C5 Complement Inhibitor Sales Price by Type (2027-2032) & (US$/unit) Table 159. SAMEA C5 Complement Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA C5 Complement Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA C5 Complement Inhibitor Sales by Application (2021-2026) & (k units) Table 162. SAMEA C5 Complement Inhibitor Sales by Application (2027-2032) & (k units) Table 163. SAMEA C5 Complement Inhibitor Sales Price by Application (2021-2026) & (US$/unit) Table 164. SAMEA C5 Complement Inhibitor Sales Price by Application (2027-2032) & (US$/unit) Table 165. SAMEA C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA C5 Complement Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA C5 Complement Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. SAMEA C5 Complement Inhibitor Sales by Country (2021-2026) & (k units) Table 170. SAMEA C5 Complement Inhibitor Sales by Country (2027-2032) & (k units) Table 171. SAMEA C5 Complement Inhibitor Sales Price by Country (2021-2026) & (US$/unit) Table 172. SAMEA C5 Complement Inhibitor Sales Price by Country (2027-2032) & (US$/unit) Table 173. Brazil C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 174. Argentina C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 175. Chile C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 176. Colombia C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 177. Peru C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 179. Israel C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 180. UAE C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 181. Turkey C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 182. Iran C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 183. Egypt C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. C5 Complement Inhibitor Distributors List Table 187. C5 Complement Inhibitor Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. C5 Complement Inhibitor Image Figure 2. Global C5 Complement Inhibitor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C5 Complement Inhibitor Market Size Share 2021 VS 2025 VS 2032 Figure 4. Eculizumab Image Figure 5. Raflizumab Image Figure 6. Global C5 Complement Inhibitor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global C5 Complement Inhibitor Market Size Share 2021 VS 2025 VS 2032 Figure 8. Paroxysmal Nocturnal Hemoglobinuria (PNH) Image Figure 9. Atypical Hemolytic Uremic Syndrome (aHUS) Image Figure 10. Other Image Figure 11. Global C5 Complement Inhibitor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global C5 Complement Inhibitor Revenue (2021-2032) & (US$ Million) Figure 13. Global C5 Complement Inhibitor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global C5 Complement Inhibitor Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global C5 Complement Inhibitor Revenue Market Share by Region (2021-2032) Figure 16. Global C5 Complement Inhibitor Sales (2021-2032) & (k units) Figure 17. Global C5 Complement Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global C5 Complement Inhibitor Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico C5 Complement Inhibitor Sales YoY (2021-2032) & (k units) Figure 20. Europe C5 Complement Inhibitor Sales YoY (2021-2032) & (k units) Figure 21. China C5 Complement Inhibitor Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) C5 Complement Inhibitor Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa C5 Complement Inhibitor Sales YoY (2021-2032) & (k units) Figure 24. Global C5 Complement Inhibitor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global C5 Complement Inhibitor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global C5 Complement Inhibitor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global C5 Complement Inhibitor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global C5 Complement Inhibitor Revenue Market Share by Type (2021-2032) Figure 30. Global C5 Complement Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global C5 Complement Inhibitor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global C5 Complement Inhibitor Sales Market Share by Type (2021-2032) Figure 33. Global C5 Complement Inhibitor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global C5 Complement Inhibitor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global C5 Complement Inhibitor Revenue Market Share by Application (2021-2032) Figure 36. Global C5 Complement Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global C5 Complement Inhibitor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global C5 Complement Inhibitor Sales Market Share by Application (2021-2032) Figure 39. North America C5 Complement Inhibitor Revenue Share by Type (2021-2032) Figure 40. North America C5 Complement Inhibitor Sales Share by Type (2021-2032) Figure 41. North America C5 Complement Inhibitor Revenue Share by Application (2021-2032) Figure 42. North America C5 Complement Inhibitor Sales Share by Application (2021-2032) Figure 43. North America C5 Complement Inhibitor Revenue Share by Country (2021-2032) Figure 44. North America C5 Complement Inhibitor Sales Share by Country (2021-2032) Figure 45. Europe C5 Complement Inhibitor Revenue Share by Type (2021-2032) Figure 46. Europe C5 Complement Inhibitor Sales Share by Type (2021-2032) Figure 47. Europe C5 Complement Inhibitor Revenue Share by Application (2021-2032) Figure 48. Europe C5 Complement Inhibitor Sales Share by Application (2021-2032) Figure 49. Europe C5 Complement Inhibitor Revenue Share by Country (2021-2032) Figure 50. Europe C5 Complement Inhibitor Sales Share by Country (2021-2032) Figure 51. China C5 Complement Inhibitor Revenue Share by Type (2021-2032) Figure 52. China C5 Complement Inhibitor Sales Share by Type (2021-2032) Figure 53. China C5 Complement Inhibitor Revenue Share by Application (2021-2032) Figure 54. China C5 Complement Inhibitor Sales Share by Application (2021-2032) Figure 55. Asia C5 Complement Inhibitor Revenue Share by Type (2021-2032) Figure 56. Asia C5 Complement Inhibitor Sales Share by Type (2021-2032) Figure 57. Asia C5 Complement Inhibitor Revenue Share by Application (2021-2032) Figure 58. Asia C5 Complement Inhibitor Sales Share by Application (2021-2032) Figure 59. Asia C5 Complement Inhibitor Revenue Share by Country (2021-2032) Figure 60. Asia C5 Complement Inhibitor Sales Share by Country (2021-2032) Figure 61. SAMEA C5 Complement Inhibitor Revenue Share by Type (2021-2032) Figure 62. SAMEA C5 Complement Inhibitor Sales Share by Type (2021-2032) Figure 63. SAMEA C5 Complement Inhibitor Revenue Share by Application (2021-2032) Figure 64. SAMEA C5 Complement Inhibitor Sales Share by Application (2021-2032) Figure 65. SAMEA C5 Complement Inhibitor Revenue Share by Country (2021-2032) Figure 66. SAMEA C5 Complement Inhibitor Sales Share by Country (2021-2032) Figure 67. C5 Complement Inhibitor Value Chain Figure 68. Manufacturing Cost Structure Figure 69. C5 Complement Inhibitor Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Eculizumab
  • Raflizumab
Applications
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Other
Companies covered
  • Alexion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 C5 Complement Inhibitor Market by Type
  3. 1.2.1 Global C5 Complement Inhibitor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Eculizumab
  5. 1.2.3 Raflizumab
  6. 1.3 C5 Complement Inhibitor Market by Application
  7. 1.3.1 Global C5 Complement Inhibitor Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Paroxysmal Nocturnal Hemoglobinuria (PNH)
  9. 1.3.3 Atypical Hemolytic Uremic Syndrome (aHUS)
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 C5 Complement Inhibitor Market Dynamics
  1. 2.1 C5 Complement Inhibitor Industry Trends
  2. 2.2 C5 Complement Inhibitor Industry Drivers
  3. 2.3 C5 Complement Inhibitor Industry Opportunities and Challenges
  4. 2.4 C5 Complement Inhibitor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global C5 Complement Inhibitor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global C5 Complement Inhibitor Revenue by Region
  3. 3.2.1 Global C5 Complement Inhibitor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global C5 Complement Inhibitor Revenue by Region (2021-2026)
  5. 3.2.3 Global C5 Complement Inhibitor Revenue by Region (2027-2032)
  6. 3.2.4 Global C5 Complement Inhibitor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global C5 Complement Inhibitor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global C5 Complement Inhibitor Sales by Region
  9. 3.4.1 Global C5 Complement Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global C5 Complement Inhibitor Sales by Region (2021-2026)
  11. 3.4.3 Global C5 Complement Inhibitor Sales by Region (2027-2032)
  12. 3.4.4 Global C5 Complement Inhibitor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global C5 Complement Inhibitor Revenue by Manufacturers
  2. 4.1.1 Global C5 Complement Inhibitor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global C5 Complement Inhibitor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global C5 Complement Inhibitor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global C5 Complement Inhibitor Sales by Manufacturers
  6. 4.2.1 Global C5 Complement Inhibitor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global C5 Complement Inhibitor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global C5 Complement Inhibitor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global C5 Complement Inhibitor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global C5 Complement Inhibitor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global C5 Complement Inhibitor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global C5 Complement Inhibitor Manufacturers, Product Type & Application
  13. 4.7 Global C5 Complement Inhibitor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global C5 Complement Inhibitor Market CR5 and HHI
  16. 4.8.2 2025 C5 Complement Inhibitor Tier 1, Tier 2, and Tier 3
5 C5 Complement Inhibitor Market by Type
  1. 5.1 Global C5 Complement Inhibitor Revenue by Type
  2. 5.1.1 Global C5 Complement Inhibitor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global C5 Complement Inhibitor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global C5 Complement Inhibitor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global C5 Complement Inhibitor Sales by Type
  6. 5.2.1 Global C5 Complement Inhibitor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global C5 Complement Inhibitor Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global C5 Complement Inhibitor Sales Market Share by Type (2021-2032)
  9. 5.3 Global C5 Complement Inhibitor Price by Type
6 C5 Complement Inhibitor Market by Application
  1. 6.1 Global C5 Complement Inhibitor Revenue by Application
  2. 6.1.1 Global C5 Complement Inhibitor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global C5 Complement Inhibitor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global C5 Complement Inhibitor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global C5 Complement Inhibitor Sales by Application
  6. 6.2.1 Global C5 Complement Inhibitor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global C5 Complement Inhibitor Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global C5 Complement Inhibitor Sales Market Share by Application (2021-2032)
  9. 6.3 Global C5 Complement Inhibitor Price by Application
7 Company Profiles
  1. 7.1 Alexion
  2. 7.1.1 Alexion Company Information
  3. 7.1.2 Alexion Business Overview
  4. 7.1.3 Alexion C5 Complement Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alexion C5 Complement Inhibitor Product Portfolio
  6. 7.1.5 Alexion Recent Developments
8 North America
  1. 8.1 North America C5 Complement Inhibitor Market Size by Type
  2. 8.1.1 North America C5 Complement Inhibitor Revenue by Type (2021-2032)
  3. 8.1.2 North America C5 Complement Inhibitor Sales by Type (2021-2032)
  4. 8.1.3 North America C5 Complement Inhibitor Price by Type (2021-2032)
  5. 8.2 North America C5 Complement Inhibitor Market Size by Application
  6. 8.2.1 North America C5 Complement Inhibitor Revenue by Application (2021-2032)
  7. 8.2.2 North America C5 Complement Inhibitor Sales by Application (2021-2032)
  8. 8.2.3 North America C5 Complement Inhibitor Price by Application (2021-2032)
  9. 8.3 North America C5 Complement Inhibitor Market Size by Country
  10. 8.3.1 North America C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America C5 Complement Inhibitor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe C5 Complement Inhibitor Market Size by Type
  2. 9.1.1 Europe C5 Complement Inhibitor Revenue by Type (2021-2032)
  3. 9.1.2 Europe C5 Complement Inhibitor Sales by Type (2021-2032)
  4. 9.1.3 Europe C5 Complement Inhibitor Price by Type (2021-2032)
  5. 9.2 Europe C5 Complement Inhibitor Market Size by Application
  6. 9.2.1 Europe C5 Complement Inhibitor Revenue by Application (2021-2032)
  7. 9.2.2 Europe C5 Complement Inhibitor Sales by Application (2021-2032)
  8. 9.2.3 Europe C5 Complement Inhibitor Price by Application (2021-2032)
  9. 9.3 Europe C5 Complement Inhibitor Market Size by Country
  10. 9.3.1 Europe C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe C5 Complement Inhibitor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China C5 Complement Inhibitor Market Size by Type
  2. 10.1.1 China C5 Complement Inhibitor Revenue by Type (2021-2032)
  3. 10.1.2 China C5 Complement Inhibitor Sales by Type (2021-2032)
  4. 10.1.3 China C5 Complement Inhibitor Price by Type (2021-2032)
  5. 10.2 China C5 Complement Inhibitor Market Size by Application
  6. 10.2.1 China C5 Complement Inhibitor Revenue by Application (2021-2032)
  7. 10.2.2 China C5 Complement Inhibitor Sales by Application (2021-2032)
  8. 10.2.3 China C5 Complement Inhibitor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia C5 Complement Inhibitor Market Size by Type
  2. 11.1.1 Asia C5 Complement Inhibitor Revenue by Type (2021-2032)
  3. 11.1.2 Asia C5 Complement Inhibitor Sales by Type (2021-2032)
  4. 11.1.3 Asia C5 Complement Inhibitor Price by Type (2021-2032)
  5. 11.2 Asia C5 Complement Inhibitor Market Size by Application
  6. 11.2.1 Asia C5 Complement Inhibitor Revenue by Application (2021-2032)
  7. 11.2.2 Asia C5 Complement Inhibitor Sales by Application (2021-2032)
  8. 11.2.3 Asia C5 Complement Inhibitor Price by Application (2021-2032)
  9. 11.3 Asia C5 Complement Inhibitor Market Size by Country
  10. 11.3.1 Asia C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia C5 Complement Inhibitor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA C5 Complement Inhibitor Market Size by Type
  2. 12.1.1 SAMEA C5 Complement Inhibitor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA C5 Complement Inhibitor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA C5 Complement Inhibitor Price by Type (2021-2032)
  5. 12.2 SAMEA C5 Complement Inhibitor Market Size by Application
  6. 12.2.1 SAMEA C5 Complement Inhibitor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA C5 Complement Inhibitor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA C5 Complement Inhibitor Price by Application (2021-2032)
  9. 12.3 SAMEA C5 Complement Inhibitor Market Size by Country
  10. 12.3.1 SAMEA C5 Complement Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA C5 Complement Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA C5 Complement Inhibitor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 C5 Complement Inhibitor Value Chain Analysis
  2. 13.1.1 C5 Complement Inhibitor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 C5 Complement Inhibitor Production Mode & Process
  6. 13.2 C5 Complement Inhibitor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 C5 Complement Inhibitor Distributors
  9. 13.2.3 C5 Complement Inhibitor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst